Drugs / TH9402
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00248365 | Nov 2005 → Aug 2007 | graft versus host disease | Kiadis Pharma | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TH9402 | “a rhodamine-derivative TH9402 (drug) and Theralux (device)” NCT00248365 ↗ |